292 related articles for article (PubMed ID: 27010561)
1. Dynamic Allostery Mediated by a Conserved Tryptophan in the Tec Family Kinases.
Chopra N; Wales TE; Joseph RE; Boyken SE; Engen JR; Jernigan RL; Andreotti AH
PLoS Comput Biol; 2016 Mar; 12(3):e1004826. PubMed ID: 27010561
[TBL] [Abstract][Full Text] [Related]
2. Identification of an allosteric signaling network within Tec family kinases.
Joseph RE; Xie Q; Andreotti AH
J Mol Biol; 2010 Oct; 403(2):231-42. PubMed ID: 20826165
[TBL] [Abstract][Full Text] [Related]
3. A conserved isoleucine maintains the inactive state of Bruton's tyrosine kinase.
Boyken SE; Chopra N; Xie Q; Joseph RE; Wales TE; Fulton DB; Engen JR; Jernigan RL; Andreotti AH
J Mol Biol; 2014 Oct; 426(21):3656-69. PubMed ID: 25193673
[TBL] [Abstract][Full Text] [Related]
4. Lipid-targeting pleckstrin homology domain turns its autoinhibitory face toward the TEC kinases.
Amatya N; Wales TE; Kwon A; Yeung W; Joseph RE; Fulton DB; Kannan N; Engen JR; Andreotti AH
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21539-21544. PubMed ID: 31591208
[TBL] [Abstract][Full Text] [Related]
5. Controlling the activity of the Tec kinase Itk by mutation of the phenylalanine gatekeeper residue.
Joseph RE; Andreotti AH
Biochemistry; 2011 Jan; 50(2):221-9. PubMed ID: 21138328
[TBL] [Abstract][Full Text] [Related]
6. Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.
James KA; Verkhivker GM
PLoS One; 2014; 9(11):e113488. PubMed ID: 25427151
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the SH3 domain from Bruton's tyrosine kinase.
Hansson H; Mattsson PT; Allard P; Haapaniemi P; Vihinen M; Smith CI; Hard T
Biochemistry; 1998 Mar; 37(9):2912-24. PubMed ID: 9485443
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families.
Guo S; Wahl MI; Witte ON
Int Immunol; 2006 Jan; 18(1):79-87. PubMed ID: 16291652
[TBL] [Abstract][Full Text] [Related]
9. Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases.
Marcotte DJ; Liu YT; Arduini RM; Hession CA; Miatkowski K; Wildes CP; Cullen PF; Hong V; Hopkins BT; Mertsching E; Jenkins TJ; Romanowski MJ; Baker DP; Silvian LF
Protein Sci; 2010 Mar; 19(3):429-39. PubMed ID: 20052711
[TBL] [Abstract][Full Text] [Related]
10. Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases.
Joseph RE; Kleino I; Wales TE; Xie Q; Fulton DB; Engen JR; Berg LJ; Andreotti AH
Sci Signal; 2013 Aug; 6(290):ra76. PubMed ID: 23982207
[TBL] [Abstract][Full Text] [Related]
11. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582.
Maniar HS; Vihinen M; Webster AD; Nilsson L; Smith CI
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S198-202. PubMed ID: 7554468
[TBL] [Abstract][Full Text] [Related]
13. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk.
Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI
FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283
[TBL] [Abstract][Full Text] [Related]
15. A specific intermolecular association between the regulatory domains of a Tec family kinase.
Brazin KN; Fulton DB; Andreotti AH
J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.
Vihinen M; Vetrie D; Maniar HS; Ochs HD; Zhu Q; Vorechovský I; Webster AD; Notarangelo LD; Nilsson L; Sowadski JM
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12803-7. PubMed ID: 7809124
[TBL] [Abstract][Full Text] [Related]
17. Achieving a Graded Immune Response: BTK Adopts a Range of Active/Inactive Conformations Dictated by Multiple Interdomain Contacts.
Joseph RE; Wales TE; Fulton DB; Engen JR; Andreotti AH
Structure; 2017 Oct; 25(10):1481-1494.e4. PubMed ID: 28867612
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK.
Forster M; Liang XJ; Schröder M; Gerstenecker S; Chaikuad A; Knapp S; Laufer S; Gehringer M
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291717
[TBL] [Abstract][Full Text] [Related]
19. A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.
Guo S; Ferl GZ; Deora R; Riedinger M; Yin S; Kerwin JL; Loo JA; Witte ON
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14180-5. PubMed ID: 15375214
[TBL] [Abstract][Full Text] [Related]
20. Screening and Characterization of Allosteric Small Molecules Targeting Bruton's Tyrosine Kinase.
Kueffer LE; Lin DY; Amatya N; Serrenho J; Joseph RE; Courtney AH; Andreotti AH
Biochemistry; 2024 Jan; 63(1):94-106. PubMed ID: 38091504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
